Evergreen Theragnostics is a Springfield, New Jersey radiopharmaceutical company founded in 2019 that operates a cGMP contract development and manufacturing organization (CDMO) for therapeutic and diagnostic radiopharmaceuticals, alongside its own clinical pipeline of theragnostic pairs including the OCTEVY PET diagnostic imaging agent for neuroendocrine tumors. Its 14,000 square foot Springfield facility carries seven commercial-scale production suites, sterility lines, quality control and packaging space serving radioligand therapy developers. Lantheus Holdings completed its acquisition of the company on April 1, 2025, and Evergreen now operates as part of Lantheus. The company sells manufacturing services and drug products, not software: it publishes no developer program, no public API, and no machine-readable specifications.
Evergreen Theragnostics is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Pharmaceuticals, Life Sciences, and Manufacturing.
Evergreen Theragnostics’ developer surface includes engineering blog and 8 more developer resources.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: evergreen-theragnostics
name: Evergreen Theragnostics
description: 'Evergreen Theragnostics is a Springfield, New Jersey radiopharmaceutical company founded in 2019 that operates
a cGMP contract development and manufacturing organization (CDMO) for therapeutic and diagnostic radiopharmaceuticals, alongside
its own clinical pipeline of theragnostic pairs including the OCTEVY PET diagnostic imaging agent for neuroendocrine tumors.
Its 14,000 square foot Springfield facility carries seven commercial-scale production suites, sterility lines, quality control
and packaging space serving radioligand therapy developers. Lantheus Holdings completed its acquisition of the company on
April 1, 2025, and Evergreen now operates as part of Lantheus. The company sells manufacturing services and drug products,
not software: it publishes no developer program, no public API, and no machine-readable specifications.'
deliveryModel:
model: saas
open_source: false
commercial: true
callable_host: false
label: Hosted service · you call their endpoint
confidence: medium
source:
- pricing
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source:
- security
generated: '2026-09-02'
method: derived
image: https://www.evergreentgn.com/wp-content/uploads/evergreen-theragnostics-og-img.jpg
url: https://raw.githubusercontent.com/api-evangelist/evergreen-theragnostics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-12'
modified: '2026-08-12'
tags:
- Company
- Healthcare
- Pharmaceuticals
- Life Sciences
- Manufacturing
- Radiopharmaceuticals
- Oncology
- Contract Manufacturing
- Medical Imaging
tags_raw:
- Company
- Health Care
- Pharmaceuticals
- Life Sciences
- Manufacturing
- Radiopharmaceuticals
- Oncology
- Contract Manufacturing
- Medical Imaging
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: DomainSecurity
url: security/evergreen-theragnostics-domain-security.yml
- type: Website
url: https://www.evergreentgn.com/
- type: About
url: https://www.evergreentgn.com/about-us/
- type: Blog
url: https://www.evergreentgn.com/news/
- type: BlogRSS
url: https://www.evergreentgn.com/feed/
- type: PrivacyPolicy
url: https://www.evergreentgn.com/privacy-policy
- type: TermsOfService
url: https://www.evergreentgn.com/terms-of-use
- type: LinkedIn
url: https://www.linkedin.com/company/evergreentgn
- type: SecondaryMarket
url: https://forgeglobal.com/evergreen-theragnostics_stock/
x-acquired-by:
company: Lantheus Holdings, Inc.
date: '2025-04-01'
source: https://lantheusholdings.gcs-web.com/news-releases/news-release-details/lantheus-completes-acquisition-evergreen-theragnostics
x-enrichment:
date: '2026-08-12'
status: minimal
artifacts_added: 2
pass: local-v1
x-coverage:
state: none
reason: not-a-software-company
detail: Evergreen Theragnostics is a cGMP radiopharmaceutical CDMO and drug developer whose product is manufactured radioligand
doses, not software — its six-page WordPress marketing site has no developer, docs, or api subdomain (all three fail to
resolve in DNS), no GitHub organization, and every /.well-known/ path returns the theme 404 page.
evidence:
- url: https://www.evergreentgn.com/.well-known/agent-card.json
status: 404
- url: https://www.evergreentgn.com/openapi.json
status: 404
- url: https://www.evergreentgn.com/llms.txt
status: 404
- url: https://api.github.com/orgs/evergreentgn
status: 404
checked: '2026-08-12'
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.
Kin Score
How this is scored →